Stroke

CREST trial for carotid artery disease therapy is expanded

Published in Drug Week, April 1st, 2005

The University of Medicine and Dentistry of New Jersey (UMDNJ) announced an expansion in scope of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) study to include asymptomatic participants, and the addition of participating trial sites from 70 to 110.

Sponsored by the National Institute of Neurological Disorders and Stroke and the National Institutes of Health, CREST is a randomized clinical trial to evaluate - in patients who are at normal risk for surgery - the efficacy of carotid artery stenting as compared to carotid endarterectomy (carotid surgery) in preventing stroke, myocardial infarction and death in the 30-day period immediately...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-04-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry